The locus control region (LCR) far upstream of the human p-like globin genes is defined by the preferential chromatin accessibilitylDNase I hypersensitivity of four constituent DNA sites"HS4, 3, 2, and 1. In an attempt to understand the mechanism of LCR function during early stages of erythropoiesis, a new polymerase chain reaction (PCR) method has been developed to examine the chromatin structure/ DNase I hypersensitivity of the LCR in progenitor cells logistically available in limited cell numbers. In erythroid progenitors as well as in multipotent cells with erythroid potential, hypersensitive sites HS4, 3, 2, and 1 were present and the chromatin structure of the LCR was accessible. Moreover, the chromatin structure of the LCR underwent dynamic URING ERYTHROPOIESIS, the pluripotent hematopoietic stem cell differentiates into mature erythrocytes through the following progenitor cell stages: multipotent colony forming units-granulocyte, erythrocyte, monocyte, and megakaryocyte ( C m -G E M ) and then lineage committed burst forming units-erythroid (BFU-E) followed by colony forming units-erythroid (CFU-E).l.2 Enhanced transcription of the pglobin gene takes place at the CFU-E ~t a g e .~.~ Transcriptional activation of the @globin gene, however, does not take place in y6p-thalassemia in which the locus control region (LCR) is deleted."" How the LCR regulates the transcription of the pglobin gene is not clearly understood. The LCR is defined by four constituent DNA sites"HS4, 3, 2, and 1 located 50 to 70 kb upstream of the p-globin gene; these sites exist in superaccessible chromatin structures in erythroid cells irrespective of whether the embryonic e-, the fetal y-, or the adult @globin gene is expressed.'"' On the basis of these and other unique properties of the hypersensitive sites, it ha$ been suggested that the DNA in HS4, 3, 2, and 1 may potentiate the ,&like globin genes for transcriptional activation during erythropoiesis by maintaining the entire globin gene locus in a generally DNase I sensitive structure; this accessible chromatin structure (transcriptional pre-activation) then permits regulatory sequences more proximal to the genes such a q the promoters to subse- 
quently respond to developmental signals and activate the globin genes at the appropriate developmental stages.'"' Functional studies show that the LCR is indeed capable of activating transcription of a cis-linked transgene in erythroid cell lines and in fetal liver and blood erythroid cells of the transgenic mice at various developmental ages."'14 Among the LCR hypersensitive sites, the DNA in HS2 has been shown to possess prominent enhancer function,"-*" and may activate a cis-linked gene by opening up the chromatin structure of the cis-linked gene domain through a transcription mechanism." The HS2 DNA contains sequence motifs that are accessible to and therefore bound by many specific transcription fxtors.'2~z5 The transcription factor-complex assembled by the HS2 enhancer may unravel and hence open up the chromatin structure of a cislinked gene domain by initiating the synthesis of long enhancer RNAs that are elongated through the intervening DNA into the gene." The DNA in HS4, 3, and 1 are also accessible to and bound by transcription f a~t o r s~~.~~ and may function as enhancer^'^^^^^'^ through a similar transcription mechanism.
Hence, accessibility of the DNA in LCR hypersensitive sites may constitute the initial condition necessary for transcriptional activation of the globin genes throughout erythropoiesis. According to this hypothesis, the DNA in HS4, 3, 2, and I should be hypersensitive to DNase I digestion in erythroid progenitor cells in which the globin genes are actively and also in multipotent progenitor cells in which the globin program may already be poised for transcriptional activation although the globin genes are not yet activated. '" To test this hypothesis, we mapped the DNase I hypersensitivity of HS4-1 in erythroid progenitors BFU-E and CFU-E and multipotent leukemic K562 cells at the CFU-GEMM stage. Recent advances in in vitro culture of peripheral blood progenitor cells in the presence of recombinant cytokines have made it possible to obtain relatively pure populations of BFU-E and CFU-E in numbers of S X IOs to IO7 cell^.^ These cell numbers are, however, 5 to 50 fold less than the cell numbers required by the traditional southem-blot hybridization method of mapping hypersensitivity.8-" We have therefore developed a more sensitive polymerase chain reaction (PCR) method to map the LCR hypersensitive sites in erythroid progenitor cells. Multipotent progenitor cells logistically available from peripheral blood'' in numbers less than IO5 are still below the processing limit of this method, For personal use only. on September 24, 2017. by guest www.bloodjournal.org From so leukemic K562 cells at the CFU-GEMM stage3' were used for the PCR mapping studies.
The method consists of first digesting with DNase I the nuclei purified from appropriate cell sources as in mapping studies by the Southern blot hybridization method.* DNAs purified from digested and control nondigested nuclei were then used as templates in PCRs with appropriate primer pairs. A set of three primer pairs was used to map each hypersensitive (HS) site (Fig IA) . The middle pair span the HS site and should produce little amplified DNA from DNase I treated nuclear DNA possessing the site; the two flanking pairs span, respectively, segments of the 5' and 3' flanking DNA, which should be relatively insensitive to DNase I digestion'"' and should therefore produce more amplified DNA product. The amplified bands were size fractionated by agarose gel electrophoresis and visualized by ethidium bromide staining. The existence of a DNase I hypersensitive site was manifested by the weaker intensity of the middle HS band relative to that of the 5' or the 3' flanking band in DNase I digested DNA samples. The PCR results show that in lineage-committed BFU-E and CFU-E as well as in multipotent K562 cells, HS4-1 were present, the chromatin structure of the LCR was in an accessible state and the transcriptional program of the globin genes was initiated. Furthermore, the transcriptional program of the globin genes underwent dynamic changes during erythropoiesis: the relative chromatin accessibility between HS2 and HS3 switched in response to changes in the cellular environment during differentiation from the BFU-E to the CFU-E stage.
MATERIALS AND METHODS
Cells. K562 and HL60 cells were cultured as previously described.8 Erythroid progenitor cells were obtained from peripheral blood of normal adult volunteers after informed consent approved by the Vanderbilt University institution review board. Day 3 BFU-E were purified from 400 mL of peripheral blood on day 1 and cultured for 2 additional days in medium containing erythropoietin and interleukin-3 (IL-3) as previously de~cribed.~ Day 3 BFU-E were a heterogeneous cell population containing approximately 60% BFU-E and up to 40% nonerythroid cells, consisting mainly of lymphocytes and macrophage^.^ Day 8 CFU-E were derived from BFU-E by culturing day 3 BFU-E in the same medium for 5 additional days.3 Since the contaminating cells in day 3 BFU-E were greatly overgrown by multiplying erythroid progenitors during 5 additional days of culture, day 8 CFU-E were a purer population containing 80% to 90% CFU-E.3
DNase I digestion of isolated nuclei. Nuclei were purified from cells' and divided into four equal aliquots, each containing lo6 of CFU-E, K562, or HL60 cells or 5 X lo4 to lo5 of BFU-E. The four aliquots of nuclei were digested with increasing concentrations of DNase I ranging from 0 to 40 pg/mL. DNA was purified from digested nuclei by proteinase K digestion and phenolkhloroform extractions.' Different concentration ranges of DNase I were used for different cell types (see legends of Figs 1, D and E, and 2A) to achieve similar size distributions of the purified DNAs as revealed by agarose gel electrophoresis. This is important for meaningful comparison of the degree of hypersensitivity of HS sites between different cell types. K562, HL60, and CFU-E DNAs of similar degree of digestion were used as templates in PCRs as described below. However, the size distribution of purified BFU-E DNA was not determined because of the small amount of available DNA. Typical yields of DNA were 2 to 4 pg from CFU-E, K562, and HL60 cells, and 120 to 200 ng from BFU-E. The nuclei digested with higher concentrations of DNase I produced lower DNA yields.
Design of PCR primers. The primer pairs were chosen according to the locations of HS4, 3, 2, and 1 previously mapped in adult marrow and fetal liver erythroid cells and leukemic cell lines by the Southern blot hybridization method.'"' The sizes of the amplified HS bands were designed to be between those of the 5' and 3' flanking bands. This was done to avoid creating bias in the intensities of the amplified HS bands. The observed digestions of the HS sites by DNase I were the combined results of preferential digestion of the HS sites and random hits by DNase I of DNA in general. The probability of random hits varies according to the size of the target DNA. The intermediate sizes of the amplified HS bands would ensure that the templates for the primer pairs spanning the HS sites were not more or less susceptible to random hits than those for the flanking primer pairs. The locations of the primer pairs used for mapping HS4-1 as presented below are based on the GenBank se- To avoid generating erroneously weaker HS bands due to uneven distribution of PCR ingredients and DNA templates, master and submaster stock solutions were used in PCRs. The master stock solution contained all the PCR ingredients except the DNA templates and the primer pairs. Each of the submaster stocks, prepared by adding a specific DNA template to an aliquot of the master stock, was then aliquoted into a set of three separate PCR tubes. To each tube, each of the three primer pairs used to map a site was added before initiating the PCR. To verify that each set of three PCR tubes used to map a site indeed contained equal amounts of genomic DNA template, a second round of PCR using a new primer pair from the gene encoding cyclic nucleotide phosphohydrolase (CNP)" or pactin was carried out for 33 cycles with 5% to 10% of the reaction contents of the first round of PCR. Attempts to eliminate the need for the second round of PCR, by carrying out multiplex PCRs in which the primer pairs for the CNP or the p-actin gene was added simultaneously with the primer pairs for the HS, the 5' or the 3' flanking DNA, were not successful. The quantitative correlation between the DNA templates and the intensities of some of the amplification bands was lost because of cross-hybridization and uneven competition for PCR ingredients among the different primers.
To avoid creating false negative results, the cycle numbers of the PCRs were carefully controlled so that the PCR ingredients were not exhausted at the end of the PCR cycles as determined by pilot experiments (Fig 1B and C DNA digested by DNase I and therefore present in a fewer number of copies. would continue amplifying the DNA template for more cycles until this reaction also stopped because of exhaustion of PCR ingredients. The S'. the 3', and the middle hypersensitive bands thus would all be amplitied to the same intensity. resulting in failure to detect the hypersensitive site.
Quorrt[ficcrriotl of PCR hands u t d cnkukrrrion of rekrtiw hypersensiti1*itirs of the HS rites. The amplified DNAs were size fractionated by electrophoresis in 2% agarose gels. The gels were stained with eithidium bromide and scanned under UV illumination in an image analyzer (Alpha Innotech. San Leandra. CA). To obtain the percentage hypersensitivity value of each HS site the pixel values of the HS band were divided by those of thc S' (or the 3 ' ) flanking band ( Table I) . To derive the relative hypersensitivity value. the percentage hypersensitivity value was normalized twice: tirst with respect to the relative intensity of the band amplified from the inter- Fig 1D legend ). Percentage hypersensitivity of HS2: the percentage of the pixel values of the scanned HS2 band relative to those of the scanned 5' flanking band. Normalized hypersensitivity: the percentage hypersensitivity of HS2 normalized with respect to the intensity of the PCR band amplified from the internal control CNP gene in each DNA template (see Fig 1D) . Relative hypersensitivity of HS2: the normalized hypersensitivity of HS2 in DNase l-digested K562 DNA expressed as a percentage relative to the normalized hypersensitivity of HS2 in nondigested control DNA.
nal control CNP or the P-actin gene to correct for possible sampling errors in setting up the PCR and next with respect to the normalized hypersensitivity value of the HS band in nondigested DNA. This latter normalization step was required to correct for possible &ffer-ences in the amplification efficiencies between the primer pair that spanned the HS site and the primer pair that spanned the flanking DNA.
RESULTS
For PCR mapping studies, four types of hematopoietic cells were used: the multipotent K562 cells at the CFU-GEMM stage, which possess erythroid potential3'; the bipotent HL60 cells at the CFU-GM stage, which do not possess erythroid potential34; and the two erythroid progenitors BFU-E and CFU-E at earlier and later stages of erythropoiesis. The K562 and HL60 cells, in which the LCR hypersensitive sites had previously been mapped by the southern technique,'"' were also used in pilot experiments for selection of optimally placed PCR primer pairs (Fig 1A) and to develop and check the validity of the PCR protocol. It should be noted that successful mapping of LCR hypersensitive sites by the new PCR method requires prior knowledge of the precise location of the HS sites determined by the Southern technique'.'' and carefully controlled PCR conditions (see Materials and Methods). Optimal PCR cycles were determined from pilot experiments (Fig 1B and C) . These experiments showed that the lower the PCR cycle numbers were, when PCR ingredients were most abundant, the more pronounced the difference in band intensities between the HS and the 5' or the 3' flanking bands (Fig 1C) . Therefore, the optimal PCR cycle numbers to use should be the minimum cycles that will produce reasonably visible bands. The lowest cycle numbers of 25 to 28 in Fig lB, however, did not produce sufficiently visible bands. The next two cycles-30 and 32 cycles-produced reasonably visible bands when the PCR ingredients were clearly not exhausted; they were therefore chosen as the standard cycle numbers that were used throughout the work presented in this report. Although 35 to 40 cycles produced even stronger bands, PCR ingredients, however, were beginning to be exhausted and the difference in band intensities between the HS and the 5' or the 3' flanking bands began to become smaller (Fig IC) . The following cell types were mapped by the optimized PCR conditions. K562 Southern mapping technique had shown previously that HS4,2, and 1, but not HS3, existed in an accessible state in K562 cells.'"" the new PCR method, however, revealed that HS4 and HS2 as well as HS3 were accessible (Fig 1D) . In each panel, the intensities of the middle HS bands relative to those of the 5' or the 3' flanking bands decreased with increasing DNase I concentrations. To obtain the hypersensitivity profiles for HS4, 3, and 2 (Fig IF) , relative hypersensitivity values for each HS site obtained as demonstrated in Table 1 were plotted with respect to increasing DNase I concentrations. Comparison of the hypersensitivity profiles showed that HS2 was a very accessible site, 50% of which was digested by DNase I at a low concentration, while HS1 (data not shown), HS3, and HS4 were less accessible sites, 30% to 50% of which were digested by DNase I only at higher concentrations. The discrepancy between the Southern and PCR methods on mapping HS3 will be discussed below in conjunction with the HL60 results.
HL60. In HL60 cells, that do not express the erythroid globin gene program,14 the Southern method failed to reveal the presence of HS4, 3, 2, and I."'" In agreement with this result, the PCR method did not reveal the presence of HS4. The relative intensities of the HS bands with respect to either the 5' or the 3' flanking bands did not decrease but increased with increasing DNase I concentration (HS4 panel, Fig 1E  and F) . This indicates that the HS4 region was actually less sensitive to DNase I digestion than the flanking DNA. In the HS3 panel, the relative intensities of the HS bands suggest the presence of HS3 site; the hypersensitivity profile, however, reveals HS3 as a relatively inaccessible site ( Fig  IF) . In the HS2 panel, the intensities of the HS bands relative to the 3' flanking bands decreased, whereas the intensities of the HS bands relative to the 5' flanking band increased with increasing DNase I concentration ( Figs 1E and F) . This indicates that the HS2 DNA was more sensitive to DNase I digestion than the 3' flanking DNA, whereas it was less sensitive to DNase I than the 5' flanking DNA. The above results suggest that HS2 was not present in HL60 cells.
The discrepancy between the absence or presence of HS3 in K562 and HL60 as determined by the Southern and PCR techniques may be due to basic technical differences between the two methods. In K562 and HL60 cells, the HS3 DNA was apparently packaged into relatively inaccessible chromatin structure digestible by DNase I only at high concentrations. Under such cleavage conditions, the DNA spanning the hypersensitive site as well as considerable amounts of the flanking DNAs was nonspecifically digested away (see Materials and Methods). The DNase I cleavage band showed up as a very faint and broad band in Southern blot hybridization, and the HS3 site was interpretated to be absent.' The weak HS3 site was therefore more clearly detectable by PCR with its power of amplification.
CFU-E. In CFU-E, PCR mapping revealed that HS4,3, 2, and 1 existed in accessible chromatin structures (Fig 2) . In the HS4, 3, and 1 panels, relative intensities of the HS bands noticeably decreased at low DNase I concentrations 
4
(lanes I through 3, Fig 2) . In the HS2 panels, however, the relative intensities of the HS bands noticeably decreased only at high concentrations of DNase I (lanes 4-6, Fig 2) . This result indicates that in CFU-E the HS2 DNA was less accessible than the DNA of the other HS sites. In multipotent K562 cells in contrast, the HS2 DNA was very accessible, yet the HS3 DNA was not as accessible. Hence, a switch in the relative accessibility between HS2 and HS3 apparently took place during erythroid differentiation between the CFU-GEMM and the CFU-E stages.
BFU-E. To determine whether the switch in chromatin accessibility of the HS2 and the HS3 sites took place before or after the BFU-E stage, the accessibility of the LCR in day 3 BFU-E was mapped by the PCR method. The results revealed that HS3 was either not present or present as a weakly accessible site in BFU-E, while HS2 was present as a much more accessible site (Fig 3) . The observation that the HS2 band in control nondigested DNA appeared weaker than the 5' or the 3' flanking band (lane 0 in HS2 panel, Fig  3A) suggests that the HS2 site in BFU-E was very accessible and was cleaved apparently even by low levels of endogenous nucleases in the absence of DNase I during nuclei preparation and DNA purification. The less accessible HS3 site was, however, apparently not digested by the endogenous nucleases (Fig 3A) .
Day 3 BFU-E contained up to 40% of lymphocytes and macrophages.' The observed hypersensitivity of HS2 and HS3 in BFU-E (Fig 3) , however, could not have been produced by those contaminating nonerythroid cells. The chromatin structure of HS2 has been shown to be inaccessible in lymphocytes and only weakly accessible in nonerythroid myeloid cells."' In HL60 with the potential to develop into macrophage^,^^ the HS2 site was shown to be absent (Fig   I F) . The above observations suggest that the contaminating cells, with either inaccessible or weakly accessible HS2 site, could not have generated the observed hypersensitivity profile representative of a very accessible HS2 site. Moreover, in pilot PCR experiments using mixed templates, in which K562 DNA purified from DNase I digested nuclei was mixed with undigested K562 DNA in a ratio of digested to undigested DNA of 80:20 and used as templates in PCR with HS2 primer pairs. the resulting hypersensitivity profile of HS2 was not significantly different from that generated by 100% digested DNA, given the average deviations of data points in hypersensitivity measurements (Fig I F) . When the ratio of digested to undigested DNA was changed to 5050, the hypersensitivity profile of HS2 produced by the mixed templates became representative of a weakly accessible site (data not shown). The results of the above experiments suggest that the likely effects of the presence of nonerythroid cells were to make the observed hypersensitivity of HS2 (Fig 1F) . The above observations suggest that although the appear weaker than it actually was in BFU-E. For the HS3 apparent hypersensitivity profiles of both HS2 and HS3 as site in BFU-E, the contaminating cells would have similarly shown in Fig 3B might have been reduced slightly by the reduced the observed HS3 hypersensitivity profile, since presence of the contaminating cells the profiles should, how-HS3 appeared to be a closed site in lymphocytes" and a ever, faithfully reflect the relative chromatin accessibility of weakly accessible site in macrophages as suggested by the HS2 and HS3 in BFU-E"HS2 being a much more accessipresence of a weakly accessible HS3 site in HL60 cells ble site than HS3. Because of the small amount of available
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From BFU-E DNA, the degree of DNA digestion measured by the molecular size distribution of the purified DNA was not determined for BFU-E samples, as it was for DNA samples of other cell types (see Materials and Methods). The hypersensitivity of the HS2 and HS3 sites in BFU-E, therefore, could be compared only with each other but not with that of the HS2 and HS3 sites in other cell types.
DISCUSSION
In this study, we have developed a new PCR method and used it to map the chromatin accessibilitylDNase I hypersensitivity of the LCR in multipotent leukemic cells and lineagecommitted erythroid progenitors. The results show that in leukemic K562 cells derived from multipotent progenitor cells at the CFU-GEMM stage possessing erythroid potential," the DNA in hypersensitive sites HS4, 3, 2, and 1 was accessible ( Fig IB through D) ; the LCR was open and the globin gene program was apparently initiated. The inducibility of the &like globin genes in K562 provides evidence that the globin gene locus is poised for transcriptional activation in multipotent hematopoietic cells. In biopotent HL60 cells at a later developmental stage of CFU-GM that do not exhibit erythroid p~t e n t i a l ,~~ HS4 and HS2 were not present and HS3 was a weakly accessible site ( Fig IE  and F) ; the LCR and the globin locus were apparently being closed down. In BFU-E and CFU-E committed to the erythroid lineage, the LCR hypersensitive sites were accessible (Figs 2 and 3) and the &like globin gene locus was main- [DNase I] + tained in a transcriptionally preactivated state so that regulatory elements proximal to the genes may be accessible to and interact with appropriate transcription factors to bring about synthesis of globin mRNAs at the maximal rate.'.4 In y6P-thalassemia in which LCR hypersensitive sites HS4, 3, and 2 were deleted, the &like globin genes as well as the regulatory elements proximal to the genes were reported to exist in a closed chromatin confo~mation.~-~ Hence, the plike globin locus was not transcriptionally preactivated in multipotent progenitor cells, and the &globin gene therefore could not be transcribed in BFU-E and CFU-E even though the &globin gene on the y6P-thalassemia chromosome was flanked by 2 to 50 kb of normal upstream DNA and therefore by the normal assortment of proximal regulatory elements. In the multipotent FDCP cells of the murine hematopoietic system, the LCR has also been reported to exist in an accessible chromatin state.'" When the FDCP cells were induced by G-/GM-CSF to differentiate into nonerythroid granulocytes and macrophages, the LCR became inaccessible and the erythroid program was closed down.3" The above observations in both the human and the murine hematopoietic system suggest that hematopoietic lineage potential may be maintained at least in part by preferential chromatin accessibility in the regulatory regions of lineage-specific genes, and that this transcriptionally potentiated state of lineage-specific genes may be initiated in multipotent cells before lineage commitment and differentiation. The above results on multipotent progenitor cells were obtained, however, from For personal use only. on September 24, 2017. by guest www.bloodjournal.org From human leukemic and murine FDCP cell lines. To what extent they reflect the status of the LCR in primary multipotent hematopoietic progenitor cells needs to be confirmed. The PCR protocol developed for the current study can potentially be scaled down 100 to 1000-fold and used to probe the chromatin accessibility of multipotent progenitor cells logistically available in numbers less than lo5 cells.
In erythroid progenitor cells following lineage commitment, the chromatin structure of the LCR hypersensitive sites remained accessible. However, the relative chromatin accessibilities between the sites changed during differentiation and maturation of the progenitor cells. In BFU-E, the DNA in HS2 was more accessible than the DNA in HS3, whereas in more mature CFU-E in which accumulation of globin transcripts reached a peak,' the HS2 DNA became less accessible than the HS3 DNA (Figs 2 and 3 ). This switch in chromatin accessibility between HS2 and HS3 in CFU-E is in agreement with earlier mapping studies in erythroid cells from human fetal liver and adult marrow using the Southern blot hybridization method.' In those heterogeneous cell populations containing CFU-E as well as later-stage erythroid cells, the HS2 site has been shown to remain in a less accessible chromatin structure than the HS3 site. Interestingly, the apparent gradual closing-down of the HS2 site and the reciprocal opening-up of the HS3 site occurred in erythroid progenitors during a period when the progenitors were downregulating their surface erythropoietin receptors and becoming gradually independent of erythropoietin for growth and maturation.' The DNA in HS2 and HS3 contain sequence motifs that are bound by many transcription factor~,*'~'~ the levels of which may vary in progenitor cells at different developmental stages in response to environmental cues including cytokine~.'~.~" It is conceivable that those transcription factors when bound to cognate DNA motifs in HS2 and HS3 may prevent the histones and other chromosomal proteins from binding to and packaging the DNA in those sites into inaccessible nucleosomal structures, thereby causing the respective sites to exhibit various degrees of DNase I hypersensitivity at different stages of erythropoiesis. Such modifications in the chromatin structure of HS2 and HS3 may initiate changes in the pattern and efficiency of globin gene transcription that are essential for differentiation and maturation of the erythroid progenitor cells.
Indeed, in agreement with the observation that the HS2 DNA was more accessible than the HS3 DNA in K562 cells (Fig 1D and  F) , functional assays showed that HS2 was a more active transcriptional enhancer than HS3 in K562 The correlation of chromatin accessibilities with enhancer activities of the DNA in the HS sites suggests that in BFU-E HS2 may be a more active enhancer than HS3, whereas in CFU-E HS3 may be more active than HS2. Hence, the HS2 enhancer may be active in early erythropoiesis from the CFU-GEMM to the BFU-E stage to potentiate the P-like globin gene locus, whereas the HS3 enhancer may be active in late erythropoiesis after the BFU-E stage. This temporal order of HS2 and HS3 function is consistent with the data in transgeneic mice of Fraser et a1,29 which we interpret to indicate that HS2 is more active than HS3 and is capable of activating the transcription of a cis-linked P-globin-gene to a higher level in adult erythroid cells.
